ClinConnect ClinConnect Logo
Search / Trial NCT05091112

Nerve Composition of Human Lumbar Dorsal Primary Rami and Its Medial Branch

Launched by UNIVERSITY OF ABERDEEN · Oct 22, 2021

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the nerves that supply the facet joints in the lower back, which are important for movement and stability. Researchers want to learn more about how these nerves are made up, especially in people who have conditions like lumbar facet arthrosis (a type of joint pain in the lower back) and nerve degeneration. This information could help improve treatments for back pain.

To participate in this trial, you must be 18 years or older and scheduled for lumbar spinal surgery. You will need to be able to give your consent to join the study. However, individuals under 18, those with certain health issues, or anyone who has had previous spinal surgery or treatments for lower back pain may not be eligible. If you join, you can expect to contribute to important research that may lead to better understanding and treatment options for back pain in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be aged 18 or over
  • be able to give informed consent
  • scheduled to undergo lumbar spinal surgery
  • Exclusion Criteria:
  • Children under 18 years old
  • Vulnerable adults
  • Adults with incapacity
  • Inability to provide informed consent
  • History of previous spinal surgery
  • history of previous RF ablation for low back pain
  • has COVID-19 or displaying symptoms of COVID-19

About University Of Aberdeen

The University of Aberdeen, a prestigious institution founded in 1495, is a leading center for research and education in healthcare and clinical sciences. With a commitment to advancing knowledge and improving patient outcomes, the university actively sponsors clinical trials that explore innovative treatments and therapies across various medical fields. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the University of Aberdeen fosters collaborations with healthcare professionals and industry partners to enhance the quality of clinical research and contribute to the global medical community.

Locations

Aberdeen, Scotland, United Kingdom

Patients applied

0 patients applied

Trial Officials

Saravanakumar Kanakarajan, MD FRCA

Principal Investigator

NHS Grampian

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials